Torres, T, Puig, L, Vender, R, Lynde, C, Piaserico, S, Carrascosa, JM, Gisondi, P, Dauden, E, Conrad, C, Mendes-Bastos, P, Ferreira, P, Leite, L, Lu, JSD, Valerio, J, Bruni, M, Messina, F, Nidegger, A, Llamas-Velasco, M, del Alcazar, E, Mufti, A, White, K, Caldarola, G, Teixeira, L, Romanelli, P, Desai, K, Gkalpakiotis, S, Romanelli, M, Yeung, JN, Nogueira, M, Chiricozzi, A. Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2021; 22(4)DOI:10.1007/s40257-021-00598-4. PMID:33786754. IF:6.233(Q1/2D).

Mahil, SK, Yates, M, Langan, SM, Yiu, ZZN, Tsakok, T, Dand, N, Mason, KJ, McAteer, H, Meynell, F, Coker, B, Vincent, A, Urmston, D, Vesty, A, Kelly, J, Lancelot, C, Moorhead, L, Bachelez, H, Bruce, IN, Capon, F, Contreras, CR, Cope, AP, de la Cruz, C, Di Meglio, P, Gisondi, P, Hyrich, K, Jullien, D, Lambert, J, Marzo-Ortega, H, McInnes, I, Naldi, L, Norton, S, Puig, L, Sengupta, R, Spuls, P, Torres, T, Warren, RB, Waweru, H, Weinman, J, Griffiths, CEM, Barker, JN, Brown, MA, Galloway, JB, Smith, CH, PsoProtect CORE-UK Study Grp. Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey. BRITISH JOURNAL OF DERMATOLOGY. 2021; 185(1)DOI:10.1111/bjd.19755. PMID:33368145. IF:11.113(Q1/1D).

Martos-Cabrera, L, Llamas-Velasco, M, Armesto, S, Herrera-Acosta, E, Vidal, D, Vilarrasa, E, Rivera-Diaz, R, de la Cueva, P, Martorell-Calatayud, A, Ballesca, F, Belinchon, I, Carretero, G, Rodriguez, L, Romero-Mate, A, Pujol-Montcusi, J, Salgado-Boquete, L, Sahuquillo-Torralba, A, Coto-Segura, P, Baniandres, O, Feltes, R, Alsina, M, Dauden, E. High adherence to secukinumab in patients with moderate to severe psoriasis: a long-term multicenter study in a daily practice setting. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2023; 62(3)DOI:10.1111/ijd.16365. PMID:35867958. IF:3.500(Q1/3D).

Muniesa C., Gallardo F., García-Doval I., Estrach M.T., Combalia A., Morillo-Andújar M., De la Cruz-Vicente F., Machan S., Moya-Martínez C., Rovira R., Sanchez-Gonzalez B., Acebo E., Amutio E., Penate, Y, Losada-Castillo, MD, García-Muret M.P., Iznardo H., Román-Curto C., Canueto, J, Fernández-de-Misa R., Flórez Á., Izu R.M., Torres-Navarro I., Zayas A., Pérez-Paredes G., Blanes M., Yanguas J.I., Pérez-Ferriols A., Callejas-Charavia M., Ortiz-Romero P.L., Pérez-Gil A., Prieto-Torres L., González-Barca E., Servitje O.. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(1)DOI:10.1111/jdv.18563. PMID:36017748. IF:8.500(Q1/1D).

Tubau, C, Cubiro, X, Amat-Samaranch, V, Garcia-Melendo, C, Puig, L, Roe-Crespo, E. Clinical and ultrasonography follow-up of five cases of calcinosis cutis successfully treated with intralesional sodium thiosulfate. Journal Of Ultrasound. 2022; 25(4)DOI:10.1007/s40477-022-00665-4. PMID:35397096. IF:(Q/D).

Puig, L. Psoriasis treatment: no more room on the summit?. BRITISH JOURNAL OF DERMATOLOGY. 2022; 187(6)DOI:10.1111/bjd.21848. PMID:36065496. IF:10.300(Q1/1D).